Cody Harris
Medical · Marion, OHNPI 1306343512
Payments from drug & device makers
Across 173 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$848
- Novo Nordisk$416
- AstraZeneca$368
- Veryan Medical Incorporated$201
- Amgen$181
- Otsuka America Pharmaceutical, Inc.$156
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,245100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $848 |
| Novo Nordisk | 29 | $416 |
| AstraZeneca | 22 | $368 |
| Veryan Medical Incorporated | 2 | $201 |
| Amgen | 9 | $181 |
| Otsuka America Pharmaceutical, Inc. | 9 | $156 |
| Corcept Therapeutics | 7 | $136 |
| GSK | 9 | $136 |
| Atricure, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Johnson & Johnson | 5 | $85 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $79 |
| Pfizer | 5 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| Lilly USA, LLC | 3 | $41 |
| Insulet Corporation | 2 | $36 |
| Medicomp Inc | 1 | $36 |
| UCB, Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Exact Sciences | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Merck | 1 | $18 |
| Verona Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioMimics$161
- SYNERGY ABLATION SYSTEM$122
How this compares
$3,245 in reported general payments places this provider in the 85th percentile of 547 medical providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 81 | $87,722 |
| TrulicityDulaglutide | 48 | $72,592 |
| EliquisApixaban | 128 | $61,745 |
| FarxigaDapagliflozin Propanediol | 38 | $34,329 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $21,721 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $20,303 |
| MounjaroTirzepatide | 19 | $19,870 |
| BriviactBrivaracetam | 16 | $16,338 |
| XareltoRivaroxaban | 15 | $14,387 |
| RybelsusSemaglutide | 13 | $13,495 |
| JardianceEmpagliflozin | 18 | $13,058 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 29 | $9,091 |
| MyrbetriqMirabegron | 36 | $7,742 |
| JanuviaSitagliptin Phosphate | 12 | $5,183 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 55 | $5,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $416 | $101,21794 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Olanzapine | $41 | $93,743112 claims |
| PfizerEliquis, Abrysvo | $75 | $70,836157 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $368 | $56,05158 claims |
| GSKTrelegy Ellipta | $136 | $20,30324 claims |
| UCB, Inc.Briviact | $34 | $16,33816 claims |
| Johnson & JohnsonXarelto | $85 | $14,38715 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $7,74236 claims |
| MerckJanuvia | $18 | $5,18312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 547 medical providers in Ohio.
Other medical in Marion
- Julia PetraitisMarion$9K
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.